From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.

From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.

Bibliographic Details
Main Authors:	Robert Colebunders, Joseph Nelson Siewe Fodjo, Adrian Hopkins, An Hotterbeekx, Thomson L Lakwo, Akili Kalinga, Makoy Yibi Logora, Maria-Gloria Basáñez
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-07-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	https://doi.org/10.1371/journal.pntd.0007407

Similar Items

Onchocerca volvulus is not detected in the cerebrospinal fluid of persons with onchocerciasis-associated epilepsy
by: An Hotterbeekx, et al.
Published: (2020-02-01)

The World Health Organization road map for neglected tropical diseases 2021–2030: implications for onchocerciasis elimination programs
by: Melissa Krizia Vieri, et al.
Published: (2021-05-01)

Onchocerciasis-associated epilepsy an unrecognised important preventable public health problem
by: R. Colebunders, et al.
Published: (2020-12-01)

Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures
by: Nolbert Gumisiriza, et al.
Published: (2020-03-01)

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
by: Robert Colebunders, et al.
Published: (2019-10-01)

High Prevalence of Epilepsy in an Onchocerciasis-Endemic Area in Mvolo County, South Sudan: A Door-To-Door Survey
by: Stephen Raimon, et al.
Published: (2021-05-01)

Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world
by: Rubén Santiago Nicholls, et al.
Published: (2018-04-01)

Financial and Economic Costs of the Elimination and Eradication of Onchocerciasis (River Blindness) in Africa.
by: Young Eun Kim, et al.
Published: (2015-01-01)

Potential Parasitic Causes of Epilepsy in an Onchocerciasis Endemic Area in the Ituri Province, Democratic Republic of Congo
by: Melissa Krizia Vieri, et al.
Published: (2021-03-01)

Urinary N-acetyltyramine-O,β-glucuronide in Persons with Onchocerciasis<i>-</i>Associated Epilepsy
by: An Hotterbeekx, et al.
Published: (2020-03-01)

The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol
by: Gasim Abd-Elfarag, et al.
Published: (2018-11-01)

From river blindness control to elimination: bridge over troubled water
by: Robert Colebunders, et al.
Published: (2018-03-01)

Onchocerciasis Elimination: Progress and Challenges
by: Lakwo T, et al.
Published: (2020-10-01)

Serotonin Levels in the Serum of Persons with Onchocerciasis-Associated Epilepsy: A Case-Control Study
by: Melissa Krizia Vieri, et al.
Published: (2021-06-01)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019-08-01)

The Role of the Maridi Dam in Causing an Onchocerciasis-Associated Epilepsy Epidemic in Maridi, South Sudan: An Epidemiological, Sociological, and Entomological Study
by: T.L. Lakwo, et al.
Published: (2020-04-01)

Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group
by: Sarah O’Neill, et al.
Published: (2019-05-01)

Report of the first international workshop on onchocerciasis-associated epilepsy
by: Robert Colebunders, et al.
Published: (2018-03-01)

Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019-07-01)

OV16 Seroprevalence among Persons with Epilepsy in Onchocerciasis Endemic Regions: A Multi-Country Study
by: Alfred Dusabimana, et al.
Published: (2020-10-01)

Commentary: Elimination of Guinea Worm Disease in South Sudan through multi-disciplinary actions
by: Makoy S. Yibi
Published: (2018-05-01)

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2018-12-01)

The Secretome of Filarial Nematodes and Its Role in Host-Parasite Interactions and Pathogenicity in Onchocerciasis-Associated Epilepsy
by: An Hotterbeekx, et al.
Published: (2021-04-01)

Single versus multiple dose ivermectin regimen in onchocerciasis-infected persons with epilepsy: A randomized clinical trial
by: M. Mandro, et al.
Published: (2020-12-01)

Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019-02-01)

Cytokines and Onchocerciasis-Associated Epilepsy, a Pilot Study and Review of the Literature
by: Melissa Krizia Vieri, et al.
Published: (2021-03-01)

Onchocerciasis-associated epilepsy: another piece in the puzzle from the Mahenge mountains, southern Tanzania
by: Christoph Kaiser, et al.
Published: (2019-05-01)

Modelling the impact of mass administration of ivermectin in the treatment of onchocerciasis (river blindness)
by: E.O. Omondi, et al.
Published: (2018-01-01)

Onchocerciasis Prevalence among Persons with Epilepsy in an Onchocerciasis Hypo-Endemic Area in the Democratic Republic of Congo: A Cross-Sectional Study
by: An Hotterbeekx, et al.
Published: (2021-03-01)

“Cross-border collaboration in onchocerciasis elimination in Uganda: progress, challenges and opportunities from 2008 to 2013”
by: Thomson Lakwo, et al.
Published: (2018-02-01)

No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy
by: An Hotterbeekx, et al.
Published: (2021-07-01)

Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo
by: Michel Mandro, et al.
Published: (2020-03-01)

High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment
by: Deby Mukendi, et al.
Published: (2019-02-01)

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.
by: Michel Mandro, et al.
Published: (2020-01-01)

Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
by: Joseph N. F. Siewe, et al.
Published: (2019-01-01)

High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo
by: Evy Lenaerts, et al.
Published: (2018-08-01)

Onchocerciasis in the Americas: from arrival to (near) elimination
by: Sauerbrey Mauricio, et al.
Published: (2011-10-01)

Burden of onchocerciasis-associated epilepsy: first estimates and research priorities
by: Natalie V. S. Vinkeles Melchers, et al.
Published: (2018-09-01)

Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo
by: Housseini Dolo, et al.
Published: (2018-12-01)

Epilepsy in the Sanaga‐Mbam valley, an onchocerciasis‐endemic region in Cameroon: electroclinical and neuropsychological findings
by: Alexandre Morin, et al.
Published: (2021-09-01)